← Open Payments lookup

HELEN SHIH: Open Payments

NPI 1750512240 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$31,613 in 63 payments from 10 companies in 2025. Trend: 2023 $23,158 · 2024 $17,020 · 2025 $31,613

Speaker / faculty: $22,301Travel & lodging: $5,816Food & beverage: $2,096Consulting: $1,400
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.29$21,826
AstraZeneca Pharmaceuticals LP19$9,352
Merck Sharp & Dohme LLC6$180
Daiichi Sankyo Inc.2$58
Rigel Pharmaceuticals, Inc.2$49
Agios Pharmaceuticals, Inc.1$35
Lilly USA, LLC1$34
Kite Pharma, Inc.1$31
Takeda Pharmaceuticals U.S.A., Inc.1$30
Celgene Corporation1$18

Products named: OPDIVO, KEYTRUDA, CALQUENCE, Vanflyta, TAVALISSE, PYRUKYND, Yescarta, VONVENDI.

Industry payments across CA — which companies pay providers there.